ImmuneAgent, a closed-loop AI system using multimodal reasoning and continual meta-learning, screens human B cell repertoires to discover broadly neutralizing antibodies across virus families, achieving a ~55% neutralization rate and ~11%…

#AI #Biotech #Immunology
https://arxiv.org/abs/2610.03160

🧪 THIS IS NOT REGULAR CLEANING.

🧪 THIS IS NOT REGULAR CLEANING.

🔬 Contamination Control
🧼 Aseptic Cleaning
📋 Documented & Traceable Procedures
✅ Audit Ready

#ContaminationControl #AsepticCleaning #Pharma #Biotech #CriticalEnvironments

Genentech pays Alector $100M for preclinical Parkinson’s prospect | #biotechsky #biotech #pharma

Introducing Fierce Biotech's 2026 Fierce 15 | #biotechsky #biotech

🐆 $JAGX +29% to 4.73 on 18.7M shares, then +34% after-hours! 🚀
📢 Special stock dividend: Series R preferred, record date Oct 13, converts to 5 common Nov 2.
⚠️ Micro-cap, down 99% YTD. Dilution risk is real. Size small. 🐢
Verify the ex-date first 🔍
@jaguarhealth.com @nasdaq.com
#JAGX #Biotech #Humble

For years, pancreatic cancer was untargettable. RevMed just flipped the script on active RAS. #biotechsky #biotech #cancer #PancreaticCancer

Full breakdown on the Target Space podcast: firebasestorage.googleapis.com/v0/b/viridia....

Signal or noise? > Cell Counting and Image Cytometry Reagents Market Forecast
to 2035, Driven by Cell and Gene Therapy Demand - IndexBox >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #competitivemarketing #pharma #pharmaceutical

Curious about what fuels the top biotechs? 🚀 Dive into their origin stories, leadership, pipelines, and investors. Tune into Pharm2Market's Target Space podcast! Listen anywhere you get your podcasts or subscribe directly: bit.ly/4AN4HTh

#Biotech #Podcasts

Curious about what fuels the top biotechs? 🚀 Dive into their origin stories, leadership, pipelines, and investors. Tune into Pharm2Market's Target Space podcast! Listen anywhere you get your podcasts or subscribe directly: bit.ly/4AN4HTh

#Biotech #Podcasts

When biotech news breaks, Pharm2Market's AI screens, tags, and annotates articles instantly! 🔍 Click on any company name for their pipeline, exec team, and investors! 📈🧬 #Biotech #News #Intelligence

Got questions? Pharm2Market's got the answers.

bit.ly/3UfeaSG

Biotech's biggest challenge? Choosing the next project! 🤔 We need a new way to evaluate beyond just finances. The Ring of Fire helps us gauge confidence in literature, biology, and market potential for smarter, data-driven choices. 🔍💡 #Biotech #Innovation #PortfolioManagement #PM

Biotech's biggest challenge? Choosing the next project! 🤔 We need a new way to evaluate beyond just finances. The Ring of Fire helps us gauge confidence in literature, biology, and market potential for smarter, data-driven choices. 🔍💡 #Biotech #Innovation #PortfolioManagement #PM

Interested in joining WIB? A new member promo is being offered through Oct. 21 with a 15% discount on member fees - use code FallintoWIB26 to apply it. Register and join our community today! 😊

engage.womeninbio.org/Web/Shared_C...

#WomenInBio #WomenInSTEM #Networking #SciSky #Biotech #Biopharma

The new Center for #OrganoidSystems (COS) combines pioneering #biotech research to better understand the human body and accelerate therapies for #cancer, #diabetes, and #cardiovasculardiseases: go.tum.de/265203

#FutureOfMedicine #HightechAgendaBayern

📷A.Heddergott

Eli Lilly:

The FDA has expanded approval of Eli Lilly’s leukemia therapy to previously untreated patients, significantly broadening the potential patient population.

Currently not in position. I expect something like this:

$LLY #Biotech #Healthcare #Stocks #Trading

BIOTECH · CSL pays $355M for Alentis' kidney and liver drug deal

The Australian drugmaker will pay up to $1.6 billion to develop a new treatment for rare kidney and liver diseases.

Read the full story →

#Biotech #CSL #TheDailyFathom

Zsolt Farkas of Evolut on why today’s longevity valuations only work if the winners spend the next decade buying everything around them.

Link as first comment.

#longevity #biotech #valuations #M&A #Evolut

Retension Pharmaceuticals, Inc. filed for an IPO
Retension Pharmaceuticals has filed for an IPO, focusing on treatments for hypertension. Their lead candidate, RTN-001, is designed to…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #pharmaceuticals #cardiovascular

I’ll be at the World Vaccine Congress Europe in Amsterdam this month, 19-21 October

Looking forward to reconnecting with colleagues, discovering new vaccine programmes, and meeting biotech teams.
Let's meet

#WVCEurope #Vaccines #Biotech #InfectiousDiseases